DavidMKoelleMD

Professor, Medicine, University of Washington School of Medicine

Dr. Koelle is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
University of Washington
750 Republican Street Room E651
Seattle, WA 98109
Phone+1 206-616-1940

Fax+1 206-616-4898

PubMed

24 citations
Cross-reactive and mono-reactive SARS-CoV-2 CD4+ T cells in prepandemic and COVID-19 convalescent individuals.
Alexandra M Johansson, Uma Malhotra, Yeseul G Kim, Rebecca Gomez, Maxwell P Krist
Plos Pathogens. 2021-12-01
49 citations
Extensive CD4 and CD8 T Cell Cross-Reactivity between Alphaherpesviruses
Lichen Jing, Kerry J. Laing, Lichun Dong, Ronnie M. Russell, Russell S. Barlow
Journal of Immunology. 2016-03-01
80 citations
Local CD4 and CD8 T-cell reactivity to HSV-1 antigens documents broad viral protein expression and immune competence in latently infected human trigeminal ganglia.
Monique van Velzen, Lichen Jing, Albert D. M. E. Osterhaus, Alessandro Sette, David M. Koelle
Plos Pathogens. 2013-08-15

Journal Articles

Varicella Zoster Virus Productively Infects Human Peripheral Blood Mononuclear Cells to Modulate Expression of Immunoinhibitory Proteins and Blocking PD-L1 Enhances Vi...
David M Koelle, Maria A Nagel, PLoS One
Viral Genetics Modulate Orolabial HSV-1 Shedding in Humans
Alex L Greninger, Eric Strachan, Keith R Jerome, David M Koelle, The Journal of Infectious Diseases
Acute Infection and Subsequent Subclinical Reactivation of Herpes Simplex Virus-2 After Vaginal Inoculation of Rhesus Macaques
Jia Zhu, David Koelle, mBio
Immunobiology of Varicella-Zoster Virus Infection
David Koelle, MD, The Journal of Infectious Diseases
Intratumoral G100, a TLR4 Agonist, Induces Anti-Tumor Immune Responses and Tumor Regression in Patients with Merkel Cell Carcinoma
Upendra Parvathaneni, David M Koelle, David Byrd, Shailender Bhatia, Michi Shinohara, Clinical Cancer Research
Join now to see all

Immunomic Therapeutics Reports Preclinical Data on Its MCPγV-LT and Her2/Neu DNA Vaccines at the American Association for Cancer Research (AACR) Annual Meeting 2022April 8th, 2022
Seattle Brothers Expand Billion-Dollar Biotech Company’s Focus to Include COVIDSeptember 25th, 2021
Study Predicts Good Passive Immunotherapy Donors to Combat COVID-19January 19th, 2021
Join now to see all

Genomic Systems Approach To Measure Hsv-1-Specific T-Cell Dominance In HumansNational Institute Of Allergy And Infectious Diseases2012
Local Determinants Of HSV-2 Shedding In HumansNational Institute Of Allergy And Infectious Diseases2008–2011
Hsv-1-Specific T-Cell Responses In Human Sensory GangliaNational Institute Of Allergy And Infectious Diseases2009–2010
Vaccinia: T-Cell Immunity And Homing To SkinNational Institute Of Allergy And Infectious Diseases2006–2009
Immune Correlates Of HSV-2 Disease SeverityNational Institute Of Allergy And Infectious Diseases2003–2007
HSV Immunotherapeutic VaccineNational Institute Of Allergy And Infectious Diseases2005
Intradermal Vaccinia:T-Cell Specificity And Skin HomingNational Institute Of Allergy And Infectious Diseases2004–2005
Mucosal T Cell Responses To HSV InfectionsNational Institute Of Allergy And Infectious Diseases1998–2002
Immune Correlates Of HSV-2 Disease SeverityNational Institute Of Allergy And Infectious Diseases2001
Lesion T Cell Response To HSV In HIV InfectionNational Cancer Institute1997–1999
Lesion CD4 T Cell Response To Human Genital HerpesNational Institute Of Allergy And Infectious Diseases1996–1998
Lesion T Cell Response To HSV In HIV InfectionNational Cancer Institute1995–1996